A Philadelphia Science Café eat. drink. science.
All events take place at 6pm the second Monday of the month at National Mechanics, 22 S. 3rd St., Philadelphia, PA 19106, unless otherwise stated. Be sure to arrive early to get seats!
What’s on tap: October 12, 2015
Cancer Science: The Quest for a Cure
Presented by the American Association for Cancer Research
Cancer. It’s only one word, yet we now know it represents more than 200 diseases. In 1907, it was a death sentence. In that year, 11 physicians and scientists came up with a novel idea to collaborate to prevent and cure cancer. They established the American Association for Cancer Research (AACR), which is headquartered right here in Philadelphia.
Today, we are still on a quest for that cure. So much progress has occurred, yet nearly 600,000 Americans still die from cancer each year. Join this month’s Science on Tap to learn about cancer science history, the trials and tribulations of scientific promise and failure. And hear about today’s latest advancements in personalized medicine and immunotherapy. There has never been a more exciting time in cancer research and treatment. Pat Morin, PhD, of the AACR will explain, in simple terms, the current state of cancer research, and will highlight the latest and greatest in our quest to identify cures for this insidious disease.
Pat Morin, PhD, is senior director of scientific review and grants administration at the American Association of Cancer Research (AACR). Following his studies in biophysics at the University of Quebec, Canada, where he received his bachelor’s and master’s degrees, Morin obtained his PhD from Boston University in 1995. He completed postdoctoral training at the Johns Hopkins Oncology Center in the laboratory of Bert Vogelstein, MD, where he studied the molecular genetics of colorectal cancer. In 1998, he joined the NIH to head a laboratory focused on ovarian cancer research. In particular, his group was one of the first to perform gene expression profiling in ovarian cancer and, in 2000, he first identified claudin proteins as being abnormally expressed in cancer. These findings led to research investigating the possible use of claudins in targeted therapies and in the detection of various cancers. He also held an assistant professor position at the Johns Hopkins School of Medicine, Department of Pathology, from 1998 until 2012, when he accepted his current position at the AACR. Morin has published over 80 peer-reviewed articles in the field of cancer. In addition, he has been on the editorial board of several journals, including Cancer Research, and has served as a reviewer of more than 250 manuscripts submitted to various scientific journals. Morin also holds several patents. He has given many lectures as an invited speaker and has chaired several scientific symposia.
October’s Science on Tap is hosted by the Mütter Museum.